KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Acquisitions (2017 - 2024)

Idexx Laboratories (IDXX) has 12 years of Acquisitions data on record, last reported at -$306000.0 in Q3 2024.

  • For Q3 2024, Acquisitions changed N/A year-over-year to -$306000.0; the TTM value through Jun 2025 reached -$306000.0, down 100.4%, while the annual FY2024 figure was $76.7 million, N/A changed from the prior year.
  • Acquisitions reached -$306000.0 in Q3 2024 per IDXX's latest filing, down from $77.0 million in the prior quarter.
  • Across five years, Acquisitions topped out at $152.1 million in Q2 2021 and bottomed at -$306000.0 in Q3 2024.
  • Average Acquisitions over 4 years is $32.9 million, with a median of $8.1 million recorded in 2021.
  • Peak YoY movement for Acquisitions: tumbled 97.0% in 2020, then surged 716.8% in 2021.
  • A 4-year view of Acquisitions shows it stood at $1.5 million in 2020, then skyrocketed by 716.8% to $12.3 million in 2021, then dropped by 6.04% to $11.5 million in 2022, then crashed by 102.66% to -$306000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Acquisitions were -$306000.0 in Q3 2024, $77.0 million in Q1 2024, and $11.5 million in Q3 2022.